|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Magdalen Centre, 1 Robert Robinson Avenue, Oxford, England OX4 4GA, GB
|
|
“One treatment a year. Life changing.”
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye. This approach provides unique and precise drug distribution to tissues specifically involved in retinal diseases. Oxular’s drug administration technology is engineered to access these critical tissues through minimally invasive delivery.
This unique combination aims to substantially improve patient quality of life by increasing therapeutic effectiveness and patient safety, while reducing side-effects and minimizing the frequency of treatments. Oxular’s product development pipeline includes treatments for prevalent retinal diseases, such as diabetic macular edema, as well as rare and orphan indications, including treatments for ocular cancers.
|
Oxular Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Oxular email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Oxular customer service number call here 01865 636 200. To contact Oxular customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.